Topic: life sciences

Pfizer Canada funds MaRS Innovation for health sciences research

Pfizer Canada has contributed $800,000 to MaRS Innovation to support new ideas or technologies in health sciences research in areas of therapeutics, diagnostic and treatment tools, and manufacturing technologies. The MaRS Innovation – Pfizer Translational Research Fund will be managed by MaRS Innovation. Priority projects are in cardiovascular disease, inflammation, immunology, rare diseases, vaccines, and…

Ontario Budget 2018 puts more support for scale-ups, startups and promising sectors

With elections just around the corner, Ontario Liberals released earlier than usual its 2018 budget, which includes at least $1.5 billion for R&D and innovation. The $158.5-billion spending plan focuses largely on enhanced social, education and healthcare initiatives but also commits millions to businesses as well as R&D, innovation and competitiveness.

Ontario creates VC fund initiative for life sciences sector

Ontario has announced a life sciences venture capital initiative to provide provincial firms with much-needed capital to grow their business. The Ontario Capital Growth Corporation (OCGC), the agency managing the province’s VC interests, is seeking fund managers who can leverage the province’s $50-million investment.